Urinary Catheters Market Size to Exceed USD 10.09 Bn by 2033

Urinary Catheters Market Reaches USD 6.58 Billion in 2026, Driven by Rising Prevalence of Urinary Disorders and Increasing Surgical Procedures

Technological Advancements and Growing Adoption of Infection-Resistant Catheters to Drive the Urinary Catheters Market to USD 10.09 Billion by 2033 at a CAGR of 6.3% – Coherent Market Insights

The Urinary Catheters Market, estimated at USD 6.58 Bn in 2026, is expected to exhibit a CAGR of 6.3% and reach USD 10.09 Bn by 2033.

The industry is witnessing significant growth driven by rising demand for advanced, reliable, and cost-effective medical devices across diagnostic, therapeutic, and monitoring applications. Rapid advancements in device design, digital health integration, and adoption of minimally invasive technologies are reshaping the competitive landscape. Furthermore, supportive regulatory frameworks, increasing healthcare investments, and the growing focus on patient-centric care are expected to create new growth avenues for market players.

Market Dynamics

The global urinary catheters market growth is attributed to two major drivers, growing geriatric population globally and rising prevalence of urinary incontinence. With improved healthcare infrastructure and increased life expectancy, the number of elderly people aged 65 years or more is growing substantially. This age group is highly susceptible to urinary disorders that require catheterization. Additionally, the prevalence of lifestyle diseases like diabetes that can damage the urinary system is on the rise. This has contributed to a higher number of people experiencing urinary incontinence issues. Both these drivers are expected to augment the demand for urinary catheters over the forecast period.

• Increasing Prevalence of Urinary Incontinence is Driving the Market Growth

Urinary incontinence refers to the accidental loss of urine and is a very common problem, especially among the elderly population. It has been estimated that nearly 25-45% of the global adult population suffers from some form of urinary incontinence. The prevalence of urinary incontinence increases substantially with age. With a growing geriatric population worldwide, the cases of urinary incontinence are expected to rise significantly in the coming years. This high and rising patient pool is creating a strong demand for various urinary catheter products for effective management of incontinence.

• Rising Number of Surgical Procedures Requiring Catheterization is Fueling the Market Growth

Another important driver for the urinary catheters market is the increasing number of surgical procedures that require catheterization post-surgery. Catheterization allows the drainage of urine from the bladder, helps monitor urine output, and prevents urinary retention and infection after surgery. There is a rising number of surgeries across various therapeutic areas like urology, gynecology, cardiac, orthopedics, and neurology worldwide which propels the demand for urinary catheters. Factors, such as the growing prevalence of target diseases, lifestyle changes, growing aging population, and advancements in surgical technologies, are contributing to the increasing surgical volume globally. This, in turn, is augmenting the uptake of urinary catheters in the post-operative care of such patients.

• Cost Sensitivity Among Consumers Impedes the Market Growth

One of the major restraints for the urinary catheters market is the cost sensitivity among consumers. Catheterization is an ongoing process which requires the frequent replacement of catheters. This increases the cost burden on patients, especially those undergoing long-term catheterization. Intermittent catheters are single-use catheters requiring multiple purchases. Indwelling catheters also need periodic replacement. This high recurring expense associated with urinary catheters restricts their adoption. Patients in underdeveloped and developing countries often cannot afford expensive catheterization and rely on cheaper alternatives which hampers market revenues. Manufacturers face pricing pressures due to cost-sensitive markets which decreases their profit margins.

• Risk of Catheter-associated Urinary Tract Infections (CAUTIs) Hinders Market Potential

The risk of catheter-associated urinary tract infections (CAUTIs) is a significant barrier that limits the growth prospects of the urinary catheters market. CAUTIs are among the most common hospital-acquired infections worldwide. Catheterization disrupts the normal defense mechanisms of the urinary tract and urethra, making it susceptible to bacterial entry. This results in infections of the urinary system. CAUTIs significantly increase patient morbidity, lengthen hospital stays, and impose enormous healthcare costs. Their high and rising incidence creates a negative perception of catheters among patients, physicians, and regulators. This limits the use of catheters only to patients with real need, restraining the potential consumer base for catheters. Manufacturers face challenges to address this critical issue and expand their clientele.

• Development of Advanced Antimicrobial Catheters Opens New Avenues

One of the major opportunities in the market is the development of technologically advanced antimicrobial urinary catheters. These catheters are coated or impregnated with antimicrobial agents like silver, minerals, or antibiotics to prevent bacterial colonization and biofilm formation on the catheter surface. This significantly reduces the risk of catheter-associated urinary tract infections. Their ability to improve patient safety and minimize healthcare costs through reduced infection rates drives their adoption. Manufacturers are increasingly focusing on such innovations to address a major market restraint and tap into the broader patient pool needing short- or long-term catheterization.

*Link: https://www.coherentmarketinsights.com/market-insight/urinary-catheters-market-1198

Key Development

• In May 2026, Cathetrix, an Israeli MedTech company and TubeX announced plans to showcase Foley-Safe and Nephro-Safe at World Health Expo 2026 in Miami. The catheter and drainage-tube securement devices are designed to reduce movement, accidental extraction, infection risk, and patient injury. Foley-Safe uses adhesive stabilization, movement control, and safety disconnection, while Nephro-Safe employs a dual-layer system to prevent nephrostomy-tube dislodgement and costly reinsertion, supporting safer hospital and homecare outcomes across U.S. healthcare settings.
• In January 2026, AAHomecare highlighted new HCPCS codes for hydrophilic intermittent catheters, effective January 1, 2026. CMS introduced A4295, A4296, and A4297 to separately classify hydrophilic straight-tip, coude-tip, and catheter-with-insertion-supplies products. The coding update is expected to improve product differentiation, reimbursement accuracy, and access to advanced catheter technologies. Suppliers, manufacturers, and payers must update billing systems before implementation to prevent reimbursement disruptions and maintain uninterrupted patient access nationwide across the United States market. (Source: AAHomecare)
• In February 2026, Johnson & Johnson, an American multinational corporation launched CEREGLIDE 42 and CEREGLIDE 57 aspiration catheters and the INNERGLIDE 7 delivery aid in the U.S., completing its CEREGLIDE stroke portfolio. Designed for aspiration-first thrombectomy, the devices feature hydrophilic coatings, variable-stiffness construction, radiopaque markers, and improved distal navigation. The expanded system aims to simplify workflows, enhance catheter compatibility, support clot removal in tortuous vessels, and strengthen treatment options for ischemic stroke patients nationwide. (Source: Johnson & Johnson)

Key Players

B. Braun SE, Coloplast Group, BD, Cathetrix, Hollister Incorporated, Boston Scientific Corporation, Medtronic, Bactiguard AB, Amecath, Urocare Products, Inc., Rocamed, Cook, Ribbel International Limited, Sonoma Pharmaceuticals, Inc., Affera, Inc., Potrero Medical, Ingenion Medical, and Otsuka Pharmaceutical Factory, Inc.